NASDAQ : DYAI
Dyadic International, Inc. — Key statistics
Healthcare · Biotechnology · United States
Last price 0.3802 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 13.85M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 13.70M |
| Enterprise Value | 15.63M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 36.44M |
| Shares Outstanding | 36.44M |
| Shares Change (YoY) | +20.08% |
| Shares Change (QoQ) | +0.11% |
| Owned by Insiders (%) | 24.54% |
| Owned by Institutions (%) | 12.98% |
| Float | 24.15M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.70 |
| Forward PS | 1.91 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 4.21 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.65 |
| Quick Ratio | 1.14 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -16.54 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -62.99% |
| Return on Invested Capital (ROIC) | -203.18% |
| Return on Capital Employed (ROCE) | -278.67% |
| Weighted Average Cost of Capital (WACC) | 8.86% |
| Revenue Per Employee | $760,447 |
| Profits Per Employee | -$1.52M |
| Employee Count | 5 |
| Asset Turnover | 0.52 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.96 |
| 52-Week Price Change | -66.73% |
| 50-Day Moving Average | 0.46 |
| 200-Day Moving Average | 0.76 |
| Relative Strength Index (RSI) | 37.08 |
| Average Volume (20 Days) | 94,623 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 194,728 |
| Short Previous Month | 179,040 |
| Short % of Shares Out | 0.53% |
| Short % of Float | 0.81% |
| Short Ratio (days to cover) | 1.12 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 3.80M |
| Gross Profit | 617,621 |
| Operating Income | -7.40M |
| Pretax Income | -7.62M |
| Net Income | -7.62M |
| EBITDA | n/a |
| EBIT | -7.40M |
| Loss Per Share | -$0.21 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 3.11M |
| Total Debt | 5.05M |
| Net Cash | -1.93M |
| Net Cash Per Share | -$0.05 |
| Equity (Book Value) | -2.39M |
| Book Value Per Share | -0.07 |
| Working Capital | 2.52M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -7.40M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | -7.40M |
| FCF Per Share | -$0.20 |
Margins
| Measure | Value |
|---|
| Gross Margin | 16.24% |
| Operating Margin | -194.50% |
| Pretax Margin | -200.46% |
| Profit Margin | -200.46% |
| EBITDA Margin | n/a |
| EBIT Margin | -194.50% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -20.08% |
| Shareholder Yield | -20.08% |
| Earnings Yield | -56.63% |
| FCF Yield | -52.62% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | 75.71% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -21.41 |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |